Total Funding
48
29
Total FundingGrant raised
Growth Score 48 in past quarter
-2 pts
Heat Score 29 in past quarter
-5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
842304
Scaffdex focuses on commercial implementation of tissue engineering.
- Tuija Annala: FounderPast Role: Tampere University, Researcher
About the Company
Scaffdex is family owned Finnish company established in Tampere in 2006. The first commercial products, CellCrown™ cell culture inserts, were developed with the researchers of Tampere University and launched in January 2007. In 2011 the first clinical tissue engineered application, RegJoint™ small joint implant, was launched. RegJoint™ is a local
innovation, which is based on research and collaboration of Tampere University of Technology and Tampere University Hospital.